Genmab A/S (GMAB)
NASDAQ: GMAB
· Real-Time Price · USD
23.29
0.31 (1.35%)
At close: Aug 15, 2025, 3:59 PM
23.28
-0.02%
After-hours: Aug 15, 2025, 07:09 PM EDT
Genmab A/S Cash Flow Statement
Financials in DKK. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 244M | 3.85B | 1.72B | 1.41B | 1.32B | 640M | 2.7B | 1.72B | 286M | 662M | 3.27B | 2.49B | 612M | 966M | 1.17B | 422M | 1.42B |
Depreciation & Amortization | 16M | 115M | 112M | 173M | 22M | 174M | 22M | 23M | 21M | 345M | 22M | 16M | 15M | 264M | 14M | 15M | 11M |
Stock-Based Compensation | 25M | 186M | 186M | 181M | 168M | 153M | 162M | 156M | 115M | 113M | 118M | 118M | 90M | 82M | 86M | 81M | 61M |
Other Working Capital | -46M | n/a | -205M | -689M | 419M | 158M | -137M | -1.5B | 2.84B | 737M | -275M | -513M | 334M | 756M | -651M | -605M | 500M |
Other Non-Cash Items | -73M | -1.19B | 540M | 449M | -231M | 874M | -528M | 209M | 112M | 1.21B | -1.03B | -1.02B | -359M | -711M | -73M | 538M | -739M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -327M | -184M | -179M | -136M | -458M | -140M | -134M | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 75M | -248M | -524M | -689M | 419M | 158M | -137M | -1.5B | 2.84B | -1.48B | -275M | -513M | 334M | -14M | -651M | -605M | 500M |
Operating Cash Flow | 287M | 2.71B | 2.03B | 1.51B | 1.51B | 1.67B | 2.04B | 436M | 3.23B | 398M | 1.97B | 959M | 587M | 241M | 447M | 355M | 1.19B |
Capital Expenditures | -30M | -94M | -48M | -27M | -28M | -67M | -98M | -107M | -104M | -110M | -82M | -68M | -57M | -68M | -77M | -79M | -28M |
Cash Acquisitions | n/a | n/a | n/a | -12.25B | n/a | 375M | -1.11B | 10M | -91M | 26M | 1.3B | 508M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -272M | -1.47B | -1.89B | -716M | -4.55B | -2.51B | -1.27B | -4.25B | -2.88B | -2.43B | -3.19B | -2.08B | -2B | -2B | -6.12B | -3.82B | -3.68B |
Sales Maturities Of Investments | 259M | 1.75B | 2.09B | 4.3B | 3.14B | 2.13B | 2.38B | 2.52B | 2.97B | 2.4B | 1.89B | 1.57B | 1.39B | 1.76B | 4.58B | 5.45B | 3.13B |
Other Investing Acitivies | -18M | -107M | 69M | -79M | -1.41B | -375M | 1.11B | -10M | 91M | -26M | -1.3B | -508M | -610M | -238M | -1.54B | 1.62B | -551M |
Investing Cash Flow | -43M | 82M | 224M | -8.77B | -1.44B | -442M | 1.01B | -1.83B | -13M | -136M | -1.38B | -576M | -667M | -306M | -1.62B | 1.54B | -579M |
Debt Repayment | -2M | n/a | -17M | -19M | -24M | -25M | n/a | -29M | -21M | -26M | -17M | -14M | -16M | -8M | -21M | -17M | -12M |
Common Stock Repurchased | n/a | -8M | -294M | -3.05B | -545M | -6M | -4M | -21M | -543M | -11M | -697M | -211M | -63M | -9M | -10M | -247M | -190M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -11M | 11M | 35M | -15M | -26M | 3M | 20M | 71M | -47M | 157M | 72M | 11M | -48M | 24M | 56M | 24M | -18M |
Financial Cash Flow | -13M | 3M | -276M | -3.05B | -595M | -22M | 20M | 7M | -611M | 131M | -642M | -214M | -64M | 16M | 24M | -240M | -220M |
Net Cash Flow | 239M | 3.52B | 2.01B | -10.34B | -197M | 594M | 3.4B | -1.41B | 2.4B | -484M | 561M | 745M | 114M | 228M | -748M | 1.58B | 632M |
Free Cash Flow | 257M | 2.62B | 1.99B | 1.49B | 1.49B | 1.6B | 1.94B | 329M | 3.13B | 288M | 1.89B | 891M | 530M | 173M | 370M | 276M | 1.16B |